Advances in potential M-protein peptide-based vaccines for preventing rheumatic fever and rheumatic heart disease (Q36685555)

15 August 2017

1 reference

title

Advances in potential M-protein peptide-based vaccines for preventing rheumatic fever and rheumatic heart disease (English)

1 reference

15 August 2017

0 references

4

Michael F Good

1 reference

15 August 2017

Michael R Batzloff

1

1 reference

15 August 2017

Manisha Pandey

series ordinal

2

1 reference

15 August 2017

Colleen Olive

series ordinal

3

1 reference

15 August 2017

publication date

1 January 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

35

1 reference

15 August 2017

issue

3

1 reference

15 August 2017

page(s)

233-248

1 reference

https://scigraph.springernature.com/pub.10.1385/ir:35:3:233

15 August 2017

exact match

0 references

cites work

Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells

1 reference

12 December 2020

New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.

1 reference

12 December 2020

Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes

1 reference

12 December 2020

Complete genome sequence of an M1 strain of Streptococcus pyogenes

1 reference

12 December 2020

A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies

1 reference

12 December 2020

Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci.

1 reference

12 December 2020

Mechanism of formation of antibodies to heart tissue in immunization with group A streptococci

1 reference

12 December 2020

Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial

1 reference

12 December 2020

Rheumatic fever following streptococcal vaccination. Report of three cases

1 reference

12 December 2020

The global burden of group A streptococcal diseases

1 reference

12 December 2020

Activation of superoxide formation and lysozyme release in human neutrophils by the synthetic lipopeptide Pam3Cys-Ser-(Lys)4. Involvement of guanine-nucleotide-binding proteins and synergism with chemotactic peptides

1 reference

12 December 2020

1 reference

12 December 2020

A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses

1 reference

12 December 2020

Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system

1 reference

12 December 2020

Technological advances in antigen delivery and synthetic peptide vaccine developmental strategies

1 reference

12 December 2020

The prediction of streptococcal pharyngitis in adults

1 reference

12 December 2020

Phagocytic, serological, and protective properties of streptococcal group A carbohydrate antibodies.

1 reference

12 December 2020

Protective Studies with Group A Streptococcal M Protein Vaccine. III. Challenge of Volunteers after Systemic or Intranasal Immunization with Type 3 or Type 12 Group A Streptococcus

1 reference

12 December 2020

Conserved T and B cell epitopes on the M protein of group A streptococci. Induction of bactericidal antibodies.

1 reference

12 December 2020

Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.

1 reference

12 December 2020

The common antigen(s) of streptococcal M protein vaccines causing hyperimmune reactions in man

1 reference

12 December 2020

Novel low-molecular-weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activator

1 reference

12 December 2020

Oral delivery of purified lipoprotein OspA protects mice from systemic infection with Borrelia burgdorferi.

1 reference

12 December 2020

National Ambulatory Medical Care Survey: 2000 summary

1 reference

12 December 2020

Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci

1 reference

12 December 2020

Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids

1 reference

12 December 2020

Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes

1 reference

12 December 2020

Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens.

1 reference

12 December 2020

Immunogenicity of a 26-valent group A streptococcal vaccine.

1 reference

12 December 2020

Structure, function, and genetics of streptococcal M protein

1 reference

12 December 2020

Lipid core peptide technology and group A streptococcal vaccine delivery.

1 reference

12 December 2020

Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus

1 reference

12 December 2020

Protection of mice from group A streptococcal infection by intranasal immunisation with a peptide vaccine that contains a conserved M protein B cell epitope and lacks a T cell autoepitope

1 reference

12 December 2020

Synthetic lipopeptide Pam3CysSer(Lys)4 is an effective activator of human platelets

1 reference

12 December 2020

Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection

1 reference

12 December 2020

Covalent binding of lipid to protein. Diglyceride and amide-linked fatty acid at the N-terminal end of the murein-lipoprotein of the Escherichia coli outer membrane.

1 reference

12 December 2020

M proteins of group A streptococci

1 reference

12 December 2020

Secondary and apparent primary antibody responses after group A streptococcal vaccination of 21 children

1 reference

12 December 2020

Lipid and carbohydrate based adjuvant/carriers in immunology

1 reference

12 December 2020

Role of secretory antibodies in the defence against infections

1 reference

12 December 2020

Acute rheumatic fever and rheumatic heart disease in the top end of Australia's Northern Territory.

1 reference

12 December 2020

Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci

1 reference

12 December 2020

1 reference

12 December 2020

Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles--report of a National Institute of Allergy and Infectious Diseases workshop.

1 reference

12 December 2020

Preclinical evaluation of a vaccine based on conserved region of M protein that prevents group A streptococcal infection

1 reference

12 December 2020

A comparative analysis of cytokine production and tolerance induction by bacterial lipopeptides, lipopolysaccharides and Staphyloccous aureus in human monocytes

1 reference

12 December 2020

Antigenicity of the M proteins of group A hemolytic streptococci. 3. Antibody responses and cutaneous hypersensitivity in humans

1 reference

12 December 2020

Systematic review of rheumatic heart disease prevalence in children in developing countries: the role of environmental factors

1 reference

12 December 2020

Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines.

1 reference

12 December 2020

Protection against group A streptococcal infection by vaccination with self-adjuvanting lipid core M protein peptides

1 reference

12 December 2020

Synthesis of the Mitogenic S-[2,3-Bis(palmitoyloxy)propyl]-N-palmitoylpentapeptide fromEscherichia coliLipoprotein

1 reference

12 December 2020

Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses

1 reference

12 December 2020

Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein

1 reference

12 December 2020

Pathogenesis of group A streptococcal infections

1 reference

12 December 2020

Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers

1 reference

12 December 2020

Protective and nonprotective epitopes from amino termini of M proteins from Australian aboriginal isolates and reference strains of group A streptococci

1 reference

12 December 2020

Stimulation of human and murine adherent cells by bacterial lipoprotein and synthetic lipopeptide analogues.

1 reference

12 December 2020

The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen

1 reference

12 December 2020

Toward the development of an antidisease, transmission-blocking intranasal vaccine for group a streptococcus

1 reference

12 December 2020

Cutting edge: Immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent.

1 reference

12 December 2020

Active and passive intranasal immunizations with streptococcal surface protein C5a peptidase prevent infection of murine nasal mucosa-associated lymphoid tissue, a functional homologue of human tonsils

1 reference

12 December 2020

Identification and assessment of new vaccine candidates for group A streptococcal infections

1 reference

12 December 2020

Primary Immunization of Infants and Children with Group A Streptococcal M Protein

1 reference

12 December 2020

Free radical induced polymerization of synthetic peptides into polymeric immunogens

1 reference

12 December 2020

Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communities.

1 reference

12 December 2020

Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technology

1 reference

12 December 2020

Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine

1 reference

12 December 2020

Lipid, sugar and liposaccharide based delivery systems.

1 reference

12 December 2020

Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A

1 reference

12 December 2020

Identifiers

DOI

10.1385/IR:35:3:233

1 reference

Dimensions Publication ID

15 August 2017

1028178929

0 references

1 reference